Biogen stock’s consensus analyst price target has ticked up slightly, moving from $172.34 to $172.55. This adjustment reflects fresh optimism around the company’s growth prospects, as well as nuanced ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback